Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
Michael Bonelli(Medical University of Vienna), Daniel Mrak(Center for Rheumatology), Selma Tobudic(Medical University of Vienna), Daniela Sieghart(Center for Rheumatology), Maximilian Koblischke(Medical University of Vienna), Péter Mandl(Medical University of Vienna), Barbara Kornek(Medical University of Vienna), Elisabeth Simader(Center for Rheumatology), Helga Radner(Center for Rheumatology), Thomas Perkmann(Medical University of Vienna), Helmuth Haslacher(Medical University of Vienna), Margareta Mayer(Medical University of Vienna), Philipp Hofer(Medical University of Vienna), Kurt Redlich(Klinik Hietzing), Emma Husar-Memmer(Hanusch Hospital), Ruth Fritsch‐Stork(Hanusch Hospital), Renate Thalhammer(Medical University of Vienna), Karin Stiasny(Medical University of Vienna), Stefan Winkler(Medical University of Vienna), Josef S Smolen(Center for Rheumatology), Judith H. Aberle(Medical University of Vienna), Markus Zeitlinger(Medical University of Vienna), Leonhard X. Heinz(Medical University of Vienna), Daniel Aletaha(Medical University of Vienna)
Cited by 60
Abstract
Related Papers
No related papers found
Powered by citation graph analysis